Medtech
ProPharma Introduces ClinCHAT, a Solution to Unleash the Power of Real-World Evidence with Conversational AI
ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio…
ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners introduced ClinCHAT, a co-developed AI-powered chatbot.
Recommended: NovelVox Introduces Intuitive Visual IVR for Cisco, Avaya, and Genesys Contact Centers
The product launch follows the announcement of ProPharma and H1’s partnership in May to optimize research and development with the inclusion of AI, data insights, and analytics. ClinCHAT is the first product from this partnership and a major advance in surfacing R&D and product insights from massive data sets to optimize and de-risk clinical research.
Through AI, ClinCHAT utilizes the latest natural language processing (NLP) and machine learning algorithms to provide a frictionless experience for users navigating complex data queries, regardless of size or development stage. The new tool gives ProPharma seamless access to H1’s real world and clinical trial performance data – which includes a database of some 340 million patients, 10 million physicians and over 420,000 clinical trials – to increase confidence and overall success in clinical research.
AiThority Interview Insights : Balancing AI and Human Insight in Content Marketing
“ClinCHAT and our continued partnership with H1 reflects ProPharma’s AI-first strategy and showcases our technology-enabled Research Consulting Organization business model,” said ProPharma’s Chief Strategy Officer and Head of Corporate Development, Bryan Katz. “ClinCHAT is an important tool for those innovators looking to de-risk decision making and accelerate the delivery of their programs with a higher probability of success.”
ProPharma is committed to improving clinical trial access through innovation. The introduction of ClinCHAT follows the launch of ProPharma’s Research Consulting Organization (RCO) model, a new type of research consulting and clinical service for biotech, pharma and device innovators to deliver bespoke solutions that bring life-saving drugs to market sooner and more cost effectively.
Recommended: AiThority Interview with Keri Olson, VP at IBM IT Automation
[To share your insights with us, please write to sghosh@martechseries.com]
The post ProPharma Introduces ClinCHAT, a Solution to Unleash the Power of Real-World Evidence with Conversational AI appeared first on AiThority.
ETF Talk: AI is ‘Big Generator’
Second nature comes alive Even if you close your eyes We exist through this strange device — Yes, “Big Generator” Artificial intelligence (AI) has…
Apple gets an appeals court win for its Apple Watch
Apple has at least a couple more weeks before it has to worry about another sales ban.
Federal court blocks ban on Apple Watches after Apple appeal
A federal appeals court has temporarily blocked a sweeping import ban on Apple’s latest smartwatches while the patent dispute winds its way through…
